CCR9 and myeloid sarcoma: Disruption of the CCR9-CCL25 interaction by the MS gut microbiota results in a depleted population of CCR9+ CD4+ T cells, suggesting another potential mechanism involved in the exacerbation of neuroinflammation in SP-MS patients.